ArticleBreast cancer research and treatment2024

Real-world treatment patterns and clinical outcomes in patients treated with eribulin after prior phosphoinositide 3-Kinase inhibitor treatment for metastatic breast cancer.

Ravi K Goyal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.